Targeting High-Risk Pregnancies: A Cost-Effectiveness Case for Low-Dose Aspirin
Published on September 22, 2026 1:14 PM GMTA century-old pill, given to the right people, could cost-effectively save many lives.SummaryTargeting low-cost prevention toward people at elevated risk may uncover highly cost-effective ways to address noncommunicable diseases. Hypertensive disorders in pregnancy could be a test case for this approach.Meta-analyses indicate that low-dose aspirin reduces perinatal death by ~20% when given to women at risk of preeclampsia, a pregnancy complication invol...
Read full article →